Editöre Mektup: ‘Hipertansiyon Tanılı Covid-19 Hastalarında Biyokimyasal Parametrelerin İncelenmesi’

Yıl 2023, Cilt: 13 Sayı: 4, 584 - 586, 30.12.2023

Ali Kırık , Özge Kama Başcı , Ayse Ergene , Hacer Şen

https://doi.org/10.31832/smj.1191209

Öz

....................................................................................................................................................

Anahtar Kelimeler

covid-19, hipertansiyon, mortalite

Destekleyen Kurum

..

Proje Numarası

..

Teşekkür

..

Kaynakça

• 1. Çekiç D, Genç AC, İşsever K ve ark. Hipertansiyon tanılı Covid-19 hastalarında fibrinojen ve d-dimer düzeylerinin incelenmesi. Sak Tıp D. Doi:10.31832/SMJ.953008
• 2. Leca BM, Mytilinaiou M, Tsoli M, et al. Identification of an optimal prolactin threshold to determine prolactinoma size using receiver operating characteristic analysis. Sci Reports |. 123AD;11:9801. doi:10.1038/s41598-021-89256-7
• 3. Mahamat-Saleh Y, Fiolet T, Rebeaud ME, et al. Open access diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies. BMJ Open. 2021;11:52777. doi:10.1136/bmjopen-2021-052777
• 4. Kompaniyets L, Goodman AB, Belay B, et al. Body mass index and risk for COVID-19 related hospitalization, intensive care unit admission, invasive mechanical ventilation, and death. United States, March–December 2020. MMWR Morb Mortal Wkly Rep. 2021;70(10):355-361. doi:10.15585/MMWR.MM7010E4
• 5. Schutte T, Thijs A, Smulders YM. Never ignore extremely elevated d-dimer levels: They are specific for serious illness. Neth J Med. 2016;74(10):443-448.